Seelaus Asset Management LLC Cytosorbents Corp Transaction History
Seelaus Asset Management LLC
- $103 Million
- Q3 2024
A detailed history of Seelaus Asset Management LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Seelaus Asset Management LLC holds 18,800 shares of CTSO stock, worth $18,236. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,800
Previous 18,800
-0.0%
Holding current value
$18,236
Previous $13,000
115.38%
% of portfolio
0.03%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.7MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$2.89 Million0.45% of portfolio
-
Skylands Capital, LLC2.76MShares$2.67 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$2.03 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.89 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.73 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $42.3M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...